Logo image
HLA‐Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy
Journal article   Open access   Peer reviewed

HLA‐Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy

A. Rauch, D. Nolan, H. Furrer, E. McKinnon, M. John, S. Mallal, S. Gaudieri, H.F. Günthard, P. Schmid, M. Battegay, …
Clinical Infectious Diseases, Vol.46(12), pp.1921-1925
2008
pdf
HLA-Bw4.pdfDownloadView
Published (Version of Record) Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

We assessed the influence of human leukocyte antigen (HLA) alleles HLA-Bw4 and HLA-Bw6 on CD4 T cell recovery after starting successful combination antiretroviral therapy in 265 individuals. The median gains in the CD4 T cell count after 4 years were 258 cells/μL for HLA-Bw4 homozygotes, 321 cells/μL for HLA-Bw4/Bw6 heterozygotes, and 363 cells/μL for HLA-Bw6 homozygotes (P = .01 , compared with HLA- Bw4 homozygotes). HLA-Bw4 homozygosity appears to predict an impaired CD4 T cell recovery after initiation of combination antiretroviral therapy.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

214 File views/ downloads
36 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.66 HIV
1.66.46 HIV Pathogenesis
Web Of Science research areas
Immunology
Infectious Diseases
Microbiology
ESI research areas
Immunology
Logo image